RUNX2 and acute myeloid leukemia: Freshly isolated human T cells and eFluor670-labeled CD33low OCI-AML3 target cells were co-incubated together with the modified hMSCs at an e:t ratio of 1:1, resembling the in vivo conditions of AML patients in acute blast crisis (with low T-cell numbers).